Skip to main content
. 2020 May 1;13(5):821–827. doi: 10.1093/ckj/sfaa054

FIGURE 3.

FIGURE 3

Prevalence of concomitant iron use in ESA-treated patients by CKD Stages 3b–5 (ND patients) or dialysis type (PD and HD patients). Percentages may not add up to 100 due to rounding.